GSK to expand in China with MeiRui acquisition

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) will acquire Nanjing MeiRui Pharma Co. Ltd. (Shanghai, China) for about $70 million in cash. GSK said the acquisition will expand its presence in China through ...